These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19689226)

  • 1. In vitro studies of the activity of newly sinthesized nociceptin / orphanin FQ receptor ligand analogues.
    Kasakov L; Nashar M; Naydenova E; Vezenkov L; Vlaskovska M
    Protein Pept Lett; 2010 May; 17(5):616-20. PubMed ID: 19689226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs.
    Ambo A; Kohara H; Kawano S; Sasaki Y
    J Pept Sci; 2007 Oct; 13(10):672-8. PubMed ID: 17712865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
    Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
    Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.
    Ho M; Corbett AD; McKnight AT
    Br J Pharmacol; 2000 Sep; 131(2):349-55. PubMed ID: 10991930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
    Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S
    Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of nociceptin/orphanin FQ(1-13)NH2 analogues modified in 9 and/or 13 position.
    Naydenova ED; Zhivkova VI; Zamfirova RN; Vezenkov LT; Dobrinova YG; Mateeva PI
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4071-4. PubMed ID: 16714110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G; Agostini S; Broccardo M; Petrella C; Improta G
    Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
    Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L
    Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
    J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor.
    Chang M; Peng YL; Dong SL; Han RW; Li W; Yang DJ; Chen Q; Wang R
    Regul Pept; 2005 Sep; 130(3):116-22. PubMed ID: 15935490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
    Calo' G; Rizzi A; Cifani C; Micioni Di Bonaventura MV; Regoli D; Massi M; Salvadori S; Lambert DG; Guerrini R
    CNS Neurosci Ther; 2011 Jun; 17(3):178-98. PubMed ID: 20497197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of novel small peptides with aminophosphonates moiety as NOP receptor ligands.
    Naydenova ED; Todorov PT; Mateeva PI; Zamfirova RN; Pavlov ND; Todorov SB
    Amino Acids; 2010 Nov; 39(5):1537-43. PubMed ID: 20499257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
    Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.